Wei Dong Yin
Chief Executive Officer chez SINOVAC BIOTECH LTD.
Fortune : 41 M $ au 31/01/2024
Profil
Wei Dong Yin is currently the Chairman, President, CEO, Secretary & MD at Sinovac Biotech Ltd.
He is also the Chairman at Tangshan Yian Biological Engineering Co., Ltd., Sinovac Biotech (Hong Kong) Ltd., Sinovac (Dalian) Vaccine Technology Co. Ltd., and President of Zhongguancun Listed Cos.
Association.
Previously, he served as the Chairman & Chief Executive Officer at Sinovac Biotech Co. Ltd.
from 2013 to 2018.
Dr. Yin holds an MBA from the National University of Singapore.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SINOVAC BIOTECH LTD.
8,87% | 31/03/2023 | 6 359 500 ( 8,87% ) | 41 M $ | 31/01/2024 |
Postes actifs de Wei Dong Yin
| Sociétés | Poste | Début |
|---|---|---|
| SINOVAC BIOTECH LTD. | Chief Executive Officer | 01/09/2003 |
Tangshan Yian Biological Engineering Co., Ltd.
 Tangshan Yian Biological Engineering Co., Ltd. BiotechnologyHealth Technology Part of Sinovac Biotech Ltd., Tangshan Yian Biological Engineering Co., Ltd. develops vaccines. The private company is based in Tangshan, China. Tangshan Yian Biological Engineering Co. was acquired by Sinovac Biotech Ltd. on January 30, 2004 for $11.86 million. | Chairman | 08/05/2013 |
| Sinovac Biotech (Hong Kong) Ltd. | Chairman | - |
Sinovac (Dalian) Vaccine Technology Co. Ltd.
 Sinovac (Dalian) Vaccine Technology Co. Ltd. BiotechnologyHealth Technology Part of Sinovac Biotech Ltd., Sinovac (Dalian) Vaccine Technology Co. Ltd. is a Chinese company that manufactures and supplies vaccines. The private company is based in Dalian, China. | Chairman | - |
| Zhongguancun Listed Cos. Association | President | - |
Anciens postes connus de Wei Dong Yin
| Sociétés | Poste | Fin |
|---|---|---|
Sinovac Biotech Co. Ltd.
 Sinovac Biotech Co. Ltd. Pharmaceuticals: MajorHealth Technology Sinovac Biotech Co., Ltd. is a biotechnology company engaged in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza and SARS. | Chief Executive Officer | 07/02/2018 |
Formation de Wei Dong Yin
| National University of Singapore | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SINOVAC BIOTECH LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Tangshan Yian Biological Engineering Co., Ltd.
Tangshan Yian Biological Engineering Co., Ltd. BiotechnologyHealth Technology Part of Sinovac Biotech Ltd., Tangshan Yian Biological Engineering Co., Ltd. develops vaccines. The private company is based in Tangshan, China. Tangshan Yian Biological Engineering Co. was acquired by Sinovac Biotech Ltd. on January 30, 2004 for $11.86 million. | Health Technology |
Sinovac Biotech Co. Ltd.
Sinovac Biotech Co. Ltd. Pharmaceuticals: MajorHealth Technology Sinovac Biotech Co., Ltd. is a biotechnology company engaged in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza and SARS. | Health Technology |
| Sinovac Biotech (Hong Kong) Ltd. | |
Sinovac (Dalian) Vaccine Technology Co. Ltd.
Sinovac (Dalian) Vaccine Technology Co. Ltd. BiotechnologyHealth Technology Part of Sinovac Biotech Ltd., Sinovac (Dalian) Vaccine Technology Co. Ltd. is a Chinese company that manufactures and supplies vaccines. The private company is based in Dalian, China. | Health Technology |
| Zhongguancun Listed Cos. Association |
